NCT06744595
Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesMayo ClinicInvestigator-initiated
~50 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:Biospecimen CollectionEducational InterventionElectronic Health Record ReviewGenetic CounselingGenetic Testing for Cancer RiskSurvey Administration
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Demographic factors affecting likelihood of patients meeting National Comprehensive Cancer Network (NCCN) guidelines
Measured over Up to 75 days
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Adrianna D. Clapp, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
First-degree relative with pancreatic cancer listed in the EPIC family history tool
Active patient at Mayo Clinic Florida (MCF) (visits within 1/1/2023-12/31/2023 to Family Medicine and/or Gastroenterology and Hepatology)
Patients with an active or past history of pancreatic cancer
Patients who are pregnant or breastfeeding
What this trial measures
- Demographic factors affecting likelihood of patients meeting National Comprehensive Cancer Network (NCCN) guidelinesUp to 75 days
Will determine whether demographic factors, including socioeconomic status, affect the likelihood of a patient meeting NCCN guidelines regarding genetic counseling for those with a family history of pancreatic cancer.